iSpecimen's market cap is currently $6.64M. The company's EPS TTM is $-0.419; its P/E ratio is ―; iSpecimen is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
